🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Dollar Weakens; Yen, Swiss Franc Favored as Omicron Fears Rise

Published 30/11/2021, 08:28
© Reuters
EUR/USD
-
GBP/USD
-
USD/JPY
-
USD/CHF
-
AUD/USD
-
NZD/USD
-
USD/CNY
-
MRNA
-

By Peter Nurse

Investing.com - The dollar retreated Tuesday as fresh concerns about the impact of the omicron coronavirus variant prompted a rush into the safe havens, the Japanese yen and the Swiss franc.

At 2:55 AM ET (0755 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, traded 0.4% lower at 95.965, at a fresh one-week low.

USD/JPY fell 0.4% to 113.11, just above Friday’s low of 113.05, while USD/CHF dropped 0.3% to 0.9204, as markets rapidly repriced the risk of interest rate hikes in the U.S.

In prepared testimony ahead of his appearance later in the Senate Banking Committee, Federal Reserve Chair Jerome Powell said the omicron variant of the coronavirus poses risks to both sides of the central bank’s mandate to achieve stable prices and maximum employment.

“The recent rise in COVID-19 cases and the emergence of the omicron variant pose downside risks to employment and economic activity and increased uncertainty for inflation,” Powell said in prepared testimony released Monday. “Greater concerns about the virus could reduce people’s willingness to work in person, which would slow progress in the labor market and intensify supply-chain disruptions.” 

Powell will likely flesh these comments out later alongside Treasury chief Janet Yellen.

Elsewhere, EUR/USD rose 0.3% to 1.1328, GBP/USD climbed 0.1% to 1.3323, off Friday’s 11-month low of 1.3278, while the risk-sensitive AUD/USD fell 0.3% to 0.7118, just above a 12-month low, and the NZD/USD dropped 0.2% to 0.6807.

This sudden burst of risk aversion followed comments from the head of drugmaker Moderna (NASDAQ:MRNA), one of the pharmaceutical companies supplying most of the developed world with vaccines to combat the Covid-19 virus, which raised concerns that the omicron variant could cause more widespread global economic disruption. 

Stephane Bancel told the Financial Times that the existing vaccines would struggle to cope with the omicron variant, predicting a ‘material drop’ in their effectiveness.

The World Health Organization has warned of a "very high" risk of infection surges from the new variant, and countries around the world have reacted quickly to tighten border controls.

President Joe Biden had boosted sentiment on Monday by stating that the United States would not reinstate lockdowns, even in the face of the uncertainty surrounding the omicron variant.

Also of interest Tuesday will be the release of the Eurozone CPI number for November, which is expected to climb to 4.5% on the year from 4.1% the previous month.

Elsewhere, USD/CNY fell 0.2% to 6.3723 after China recorded surprise growth in factory activity in November, the first in three months, as its manufacturing purchasing managers index came in at 50.1, higher than the previous month’s 49.2 figure.

The non-manufacturing PMI was at 52.3, higher than the previous month’s 52.4 figure.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.